Disclosed positions

Estimated from their latest filings — positions may have changed since

$9.36M

combined est. value

Stock	Shares	Price	Value	Weight	As of
TSHATaysha Gene Therapies, Inc.	1,442,131	$6.49	$9.36M	100%	2026-02-04

TSHA

Taysha Gene Therapies, Inc.

$9.36M

1,442,131 sh

All filings on record

Every Form 4 transaction we track for this filer

all 5buys 0sells 4

Stock	Transaction	Date	~6mo later
TSHATaysha Gene Therapies, Inc.	Sell $7.5K · 1,655 sh	2026-02-04	—
TSHATaysha Gene Therapies, Inc.	Sell $109.9K · 23,849 sh	2026-01-26	—
TSHATaysha Gene Therapies, Inc.	Sell $375.1K · 78,968 sh	2026-01-23	—
TSHATaysha Gene Therapies, Inc.	Grant — · 359,000 sh	2026-01-12	—
TSHATaysha Gene Therapies, Inc.	Sell $155.3K · 54,491 sh	2025-08-21	—

TSHASell

2026-02-04 · Taysha Gene Therapies, Inc.

$7.5K

—

TSHASell

2026-01-26 · Taysha Gene Therapies, Inc.

$109.9K

—

TSHASell

2026-01-23 · Taysha Gene Therapies, Inc.

$375.1K

—

TSHAGrant

2026-01-12 · Taysha Gene Therapies, Inc.

359,000

—

TSHASell

2025-08-21 · Taysha Gene Therapies, Inc.

$155.3K

—

Outcomes measure each disclosed buy against the closing price ~6 months (120 trading days) later, with the S&P 500 over the same span for context. Pre-scheduled 10b5-1 plan trades are excluded from the record. Positions are estimated from the latest reported post-transaction holdings, split-adjusted, at the latest close. Built from SEC Form 4 filings and market prices — past outcomes, not predictions or advice.